Search for tag: "chemical industry"

5 Media

The Opioid Opportunity: Laws, Ethics and… duration 1 hour 15 minutes The Opioid Opportunity: Laws, Ethics and… The Opioid Opportunity: Laws, Ethics and Community Impact - September 17, 2019	The Opioid Opportunity: Laws, Ethics and Community Impact - September 17, 2019 Featuring Andy Aylesworth (Marketing), Miriam Boeri (Sociology), Liz Brown (Law, Tax and Financial Planning), Jeff Moriarty (Philosophy) and Zoe Wagner (Natural and Applied Sciences) We’ll be… drugs and medicines medicine and intoxicants deaths caused by drugs & medicines opioids drugs opiates chemical industry right to prescribe medication medicinal chemical and botanical products pharmaceutical industry health care business drug prescriptions johnson & johnson drug companies & manufacture of pharmaceuticals purdue pharma drugs affecting central nervous system settlement (litigation) pain (health) painkillers caption complete From Kaltura MediaUser 210 plays
Frugal Innovation Creating a Path to a Healthier… duration 1 hour 0 minutes Frugal Innovation Creating a Path to a Healthier… Frugal Innovation Creating a Path to a Healthier Society - February 20, 2019	Frugal Innovation Creating a Path to a Healthier Society - February 20, 2019 A fireside chat with Dr. Gary J. Nabel, M.D., Ph.D. Dr. Gary J. Nabel, M.D., Ph.D., is Chief Scientific Officer, Global Research and Development, and Head of the North American R&D Hub at… drugs and medicines medicine and intoxicants diseases business business model drugs antibody chemical industry antibiotics medicinal chemical and botanical products business markets pharmaceutical industry health care business health care drug companies & manufacture of pharmaceuticals effects patients syndromes and disorders sanofi bacteria caption complete From Kaltura MediaUser 22 plays
Recognizing and Addressing Pseudoscience in… duration 1 hour 6 minutes Recognizing and Addressing Pseudoscience in… Recognizing and Addressing Pseudoscience in Marketing - February 27, 2019	Recognizing and Addressing Pseudoscience in Marketing - February 27, 2019 Valente Center 2019 Distinguished Visiting Scholar Dr. Jay Labov Fireside Chat with Dr. Xue Simon drugs and medicines medicine and intoxicants genetics food and drug administration (fda) health care business drugs food safety chemical industry testing of pharmaceutics science (general) pharmaceutical industry medicine safety & regulatory oversight united states department of health healthcare policy effects conversation clinical trial caption complete From Kaltura MediaUser 14 plays
From Basic Science to Better Medicines: A… duration 1 hour 10 minutes From Basic Science to Better Medicines: A… From Basic Science to Better Medicines: A Round-Table Discussion with Congresswoman Katherine Clark - April 23, 2018	From Basic Science to Better Medicines: A Round-Table Discussion with Congresswoman Katherine Clark - April 23, 2018 Ekaterina Cleary, Bentley research associate and lead author of the study; Deborah Dunsire, CEO of Xtuit Pharmaceuticals; Chris Garabedian, CEO of Xontogeny; Mark Namchuk, senior vice president of… panel discussions effects rare medical condition pharmaceutical industry caption complete medicine drugs opioids healthcare sector diseases health care business chemical industry university & college drugs and medicines health care syndromes and disorders and intoxicants conversation biotechnology research From Kaltura MediaUser 42 plays
Bringing New Medicines to Market - April 3, 2018 duration 1 hour 15 minutes Bringing New Medicines to Market - April 3, 2018 Bringing New Medicines to Market - April 3, 2018	Bringing New Medicines to Market - April 3, 2018 Bentley alumnus Lance Colwell, and MIldon Farrwell, from Biogen, discuss the commercial launch of a revolutionary new product, Spiranza biotechnology and intoxicants food and drug administration (fda) biogen idec genes medicine effects drugs and medicines chemical industry patients conversation healthcare sector testing of pharmaceutics patience diseases drugs caption7day caption complete business pharmaceutical industry syndromes and disorders health care health care business rare medical condition From Kaltura MediaUser 82 plays